035 - Empagliflozin and dulaglutide - a podcast by Sean P. Kane, PharmD; Khyati Patel, PharmD
from 2015-11-24T15:03:56
::
::
In this episode, we discuss two new anti-diabetic medications: empagliflozin (Jardiance) and the EMPA-REG OUTCOME trial as well as dulaglutide (Trulicity), a new GLP1 agonist.
Further episodes of HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
Further podcasts by Sean P. Kane, PharmD; Khyati Patel, PharmD
Website of Sean P. Kane, PharmD; Khyati Patel, PharmD